Spire Wealth Management Jazz Pharmaceuticals PLC Transaction History
Spire Wealth Management
- $2.7 Billion
- Q2 2025
A detailed history of Spire Wealth Management transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Spire Wealth Management holds 49 shares of JAZZ stock, worth $6,737. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49
Previous 278
82.37%
Holding current value
$6,737
Previous $34,000
85.29%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding JAZZ
# of Institutions
564Shares Held
62.5MCall Options Held
563KPut Options Held
77.8K-
Black Rock Inc. New York, NY6.15MShares$845 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.09MShares$837 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.55MShares$351 Million0.65% of portfolio
-
Capital World Investors Los Angeles, CA2.54MShares$350 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.54MShares$349 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.62B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...